{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:52:49Z","timestamp":1761238369806,"version":"3.40.5"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T00:00:00Z","timestamp":1488758400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.yexmp.2017.02.008","type":"journal-article","created":{"date-parts":[[2017,2,14]],"date-time":"2017-02-14T14:16:23Z","timestamp":1487081783000},"page":"237-246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["TB-IRIS: Proteomic analysis of in vitro PBMC responses to Mycobacterium tuberculosis and response modulation by dexamethasone"],"prefix":"10.1016","volume":"102","author":[{"given":"Liam","family":"Bell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janique M.","family":"Peyper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaun","family":"Garnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabecca","family":"Tadokera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2753-1800","authenticated-orcid":false,"given":"Robert","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graeme","family":"Meintjes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan M.","family":"Blackburn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.yexmp.2017.02.008_bb0005","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/nrmicro2712","article-title":"Immune reconstitution inflammatory syndrome: the trouble with immunity when you had none","volume":"10","author":"Barber","year":"2012","journal-title":"Nat. Rev. Microbiol."},{"issue":"12","key":"10.1016\/j.yexmp.2017.02.008_bb0010","first-page":"1132","article-title":"Mycobacterium avium complex causing endobronchial disease in AIDS patients after partial immune restoration","volume":"3","author":"Bartley","year":"1999","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.yexmp.2017.02.008_bb0015","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nature09247","article-title":"An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis","volume":"466","author":"Berry","year":"2010","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.yexmp.2017.02.008_bb0020","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.4049\/jimmunol.0804020","article-title":"Tuberculosis-associated immune restoration syndrome in HIV-1-infected patients involves tuberculin-specific CD4 Th1 cells and KIR-negative gammadelta T cells","volume":"183","author":"Bourgarit","year":"2009","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.yexmp.2017.02.008_bb0025","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/thx.2003.019224","article-title":"Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection","volume":"59","author":"Breen","year":"2004","journal-title":"Thorax"},{"issue":"11","key":"10.1016\/j.yexmp.2017.02.008_bb0030","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1086\/425742","article-title":"Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy","volume":"39","author":"Breton","year":"2004","journal-title":"Clin. Infect. Dis."},{"issue":"15","key":"10.1016\/j.yexmp.2017.02.008_bb0035","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1002\/pmic.200401239","article-title":"Proteomics of human umbilical vein endothelial cells applied to etoposide-induced apoptosis","volume":"5","author":"Bruneel","year":"2005","journal-title":"Proteomics"},{"issue":"12","key":"10.1016\/j.yexmp.2017.02.008_bb0040","first-page":"1282","article-title":"Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis","volume":"11","author":"Burman","year":"2007","journal-title":"Int. J. Tuberc. Lung Dis."},{"issue":"1","key":"10.1016\/j.yexmp.2017.02.008_bb0045","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/infdis\/jis499","article-title":"Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response","volume":"207","author":"Cliff","year":"2013","journal-title":"J. Infect. Dis."},{"issue":"database issue","key":"10.1016\/j.yexmp.2017.02.008_bb0050","first-page":"D191","article-title":"Activities at the universal protein resource (UniProt)","volume":"42","author":"Consortium","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.yexmp.2017.02.008_bb0055","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/pmic.200900375","article-title":"A guided tour of the trans-proteomic pipeline","volume":"10","author":"Deutsch","year":"2010","journal-title":"Proteomics"},{"key":"10.1016\/j.yexmp.2017.02.008_bb0060","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1002\/elps.200900210","article-title":"The consequences of sample pooling in proteomics: an empirical study","volume":"30","author":"Diz","year":"2009","journal-title":"Electrophoresis"},{"issue":"1","key":"10.1016\/j.yexmp.2017.02.008_bb0065","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11904-007-0003-z","article-title":"Disorders of immune reconstitution in patients with HIV infection responding to antiretroviral therapy","volume":"4","author":"French","year":"2007","journal-title":"Curr. HIV\/AIDS Rep."},{"issue":"11","key":"10.1016\/j.yexmp.2017.02.008_bb0070","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1097\/00002030-199211000-00009","article-title":"Zidovudine-induced restoration of cell-mediated immunity to mycobacteria in immunodeficient HIV-infected patients","volume":"6","author":"French","year":"1992","journal-title":"AIDS"},{"issue":"7","key":"10.1016\/j.yexmp.2017.02.008_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011416","article-title":"Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infection","volume":"5","author":"Grant","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.yexmp.2017.02.008_bb0080","first-page":"6","article-title":"Providing HIV care for co-infected tuberculosis patients: a perspective from sub-Saharan Africa","volume":"13","author":"Harries","year":"2009","journal-title":"Int. J. Tuberc. Lung Dis."},{"issue":"1","key":"10.1016\/j.yexmp.2017.02.008_bb0085","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1586\/14760584.3.1.23","article-title":"Antibody regulation of T-cell immunity: implications for vaccine strategies against intracellular pathogens","volume":"3","author":"Igietseme","year":"2004","journal-title":"Expert Rev. Vaccines"},{"issue":"6","key":"10.1016\/j.yexmp.2017.02.008_bb0090","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0959-440X(00)00149-4","article-title":"The tumour necrosis factor receptor family: life or death choices","volume":"10","author":"Jones","year":"2000","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.yexmp.2017.02.008_bb0095","article-title":"In-depth profiling of the peripheral blood mononuclear cells proteome for clinical blood proteomics","volume":"2014","author":"Kon\u010darevi\u0107","year":"2014","journal-title":"Int. J. Prosthodont."},{"issue":"2","key":"10.1016\/j.yexmp.2017.02.008_bb0100","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1128\/CMR.00042-10","article-title":"HIV and tuberculosis: a deadly human syndemic","volume":"24","author":"Kwan","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.yexmp.2017.02.008_bb0105","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/eji.201343632","article-title":"The immunopathogenesis of the HIV tuberculosis immune reconstitution inflammatory syndrome","volume":"43","author":"Lai","year":"2013","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.yexmp.2017.02.008_bb0110","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/COH.0b013e32832c7d61","article-title":"Epidemiology of HIV-associated tuberculosis","volume":"4","author":"Lawn","year":"2009","journal-title":"Curr. Opin. HIV AIDS"},{"issue":"3","key":"10.1016\/j.yexmp.2017.02.008_bb0115","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1086\/381033","article-title":"Pyomyositis and cutaneous abscesses due to Mycobacterium avium: an immune reconstitution manifestation in a patient with AIDS","volume":"38","author":"Lawn","year":"2004","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.yexmp.2017.02.008_bb0120","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1473-3099(05)70140-7","article-title":"Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals","volume":"5","author":"Lawn","year":"2005","journal-title":"Lancet Infect. Dis."},{"issue":"3","key":"10.1016\/j.yexmp.2017.02.008_bb0125","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/QAD.0b013e328011efac","article-title":"Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa","volume":"21","author":"Lawn","year":"2007","journal-title":"AIDS"},{"issue":"4","key":"10.1016\/j.yexmp.2017.02.008_bb0130","doi-asserted-by":"crossref","first-page":"e283","DOI":"10.1016\/j.ijid.2009.05.016","article-title":"Immune reconstitution inflammatory syndrome associated with Mycobacterium tuberculosis infection: a systematic review","volume":"14","author":"Leone","year":"2010","journal-title":"Int. J. Infect. Dis."},{"issue":"10","key":"10.1016\/j.yexmp.2017.02.008_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026938","article-title":"Functional correlations of pathogenesis-driven gene expression signatures in tuberculosis","volume":"6","author":"Maertzdorf","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.yexmp.2017.02.008_bb0140","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/QAI.0b013e3181594c8c","article-title":"Immune reconstitution inflammatory syndrome: risk factors and treatment implications","volume":"46","author":"Manabe","year":"2007","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"6","key":"10.1016\/j.yexmp.2017.02.008_bb0145","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jinf.2006.01.002","article-title":"Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy","volume":"53","author":"Manosuthi","year":"2006","journal-title":"J. Infect."},{"key":"10.1016\/j.yexmp.2017.02.008_bb0150","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1100\/tsw.2007.224","article-title":"Effects of glucocorticoids on apoptosis and clearance of apoptotic cells","volume":"7","author":"McColl","year":"2007","journal-title":"Sci. World J."},{"issue":"4","key":"10.1016\/j.yexmp.2017.02.008_bb0155","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/COH.0b013e3282fe6e84","article-title":"Prevention and treatment of the immune reconstitution inflammatory syndrome","volume":"3","author":"Meintjes","year":"2008","journal-title":"Curr. Opin. HIV AIDS"},{"issue":"3","key":"10.1016\/j.yexmp.2017.02.008_bb0160","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4102\/sajhivmed.v13i3.125","article-title":"Guidelines for antiretroviral therapy in adults","volume":"13","author":"Meintjes","year":"2012","journal-title":"South. Afr. J. HIV Med."},{"issue":"10","key":"10.1016\/j.yexmp.2017.02.008_bb0165","first-page":"410","article-title":"A practical approach to the diagnosis and management of paradoxical tuberculosis immune reconstitution inflammatory syndrome","volume":"29","author":"Meintjes","year":"2011","journal-title":"Contin. Med. Educ."},{"issue":"8","key":"10.1016\/j.yexmp.2017.02.008_bb0170","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1473-3099(08)70184-1","article-title":"Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings","volume":"8","author":"Meintjes","year":"2008","journal-title":"Lancet Infect. Dis."},{"issue":"10","key":"10.1016\/j.yexmp.2017.02.008_bb0175","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1164\/rccm.200806-858OC","article-title":"Type 1 helper T cells and FoxP3-positive T cells in HIV\u2013tuberculosis-associated immune reconstitution inflammatory syndrome","volume":"178","author":"Meintjes","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"15","key":"10.1016\/j.yexmp.2017.02.008_bb0180","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1097\/QAD.0b013e32833dfc68","article-title":"Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome","volume":"24","author":"Meintjes","year":"2010","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.yexmp.2017.02.008_bb0185","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/135965350501000303","article-title":"Clinical characteristics of IRIS syndrome in patients with HIV and tuberculosis","volume":"10","author":"Michailidis","year":"2005","journal-title":"Antivir. Ther."},{"issue":"5","key":"10.1016\/j.yexmp.2017.02.008_bb0190","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/QAD.0b013e3282f4a607","article-title":"Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study","volume":"22","author":"Murdoch","year":"2008","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.yexmp.2017.02.008_bb0195","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.2217\/fmb.15.9","article-title":"Paradoxical TB-IRIS in HIV-infected adults: a systematic review and meta-analysis","volume":"10","author":"Namale","year":"2015","journal-title":"Future Microbiol"},{"issue":"5","key":"10.1016\/j.yexmp.2017.02.008_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063541","article-title":"Paradoxical tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in HIV patients with culture confirmed pulmonary tuberculosis in India and the potential role of IL-6 in prediction","volume":"8","author":"Narendran","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.yexmp.2017.02.008_bb0205","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1021\/pr8010099","article-title":"Statistical design of quantitative mass spectrometry-based proteomic experiments","volume":"8","author":"Oberg","year":"2009","journal-title":"J. Proteome Res."},{"issue":"1","key":"10.1016\/j.yexmp.2017.02.008_bb0210","first-page":"71","article-title":"Paradoxical responses in a cohort of HIV-1-infected patients with mycobacterial disease","volume":"6","author":"Olalla","year":"2002","journal-title":"Int. J. Tuberc. Lung Dis."},{"issue":"7","key":"10.1016\/j.yexmp.2017.02.008_bb0215","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1021\/pr800127y","article-title":"Rapid and accurate peptide identification from tandem mass spectra","volume":"7","author":"Park","year":"2008","journal-title":"J. Proteome Res."},{"issue":"3","key":"10.1016\/j.yexmp.2017.02.008_bb0220","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1386-6532(01)00200-1","article-title":"Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy","volume":"22","author":"Price","year":"2001","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.yexmp.2017.02.008_bb0225","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000173703","article-title":"Non-opsonic recognition of mycobacterium tuberculosis by phagocytes","volume":"1","author":"Schafer","year":"2009","journal-title":"J. Innate Immun."},{"issue":"2","key":"10.1016\/j.yexmp.2017.02.008_bb0230","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1378\/chest.122.2.597","article-title":"Reconstitution of immune responses to tuberculosis in patients with HIV infection who receive antiretroviral therapy","volume":"122","author":"Schluger","year":"2002","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.yexmp.2017.02.008_bb0235","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1183\/09031936.00110210","article-title":"Clinical management of tuberculosis and HIV-1 co-infection","volume":"36","author":"Schutz","year":"2010","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.yexmp.2017.02.008_bb0240","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/01.aids.0000161769.06158.8a","article-title":"Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy","volume":"19","author":"Shelburne","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.yexmp.2017.02.008_bb0245","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1038\/nprot.2006.468","article-title":"In-gel digestion for mass spectrometric characterization of proteins and proteomes","volume":"1","author":"Shevchenko","year":"2007","journal-title":"Nat. Protoc."},{"issue":"6","key":"10.1016\/j.yexmp.2017.02.008_bb0250","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1473-3099(07)70085-3","article-title":"Immune reconstitution syndrome associated with opportunistic mycoses","volume":"7","author":"Singh","year":"2007","journal-title":"Lancet Infect. Dis."},{"issue":"10","key":"10.1016\/j.yexmp.2017.02.008_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046481","article-title":"Altered ratio of IFN-\u03b3\/IL-10 in patients with drug resistant Mycobacterium tuberculosis and HIV-tuberculosis immune reconstitution inflammatory syndrome","volume":"7","author":"Skolimowska","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.yexmp.2017.02.008_bb0260","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1021\/pr801109k","article-title":"Improvements to the percolator algorithm for peptide identification from shotgun proteomics data sets","volume":"8","author":"Spivak","year":"2009","journal-title":"J. Proteome Res."},{"issue":"4","key":"10.1016\/j.yexmp.2017.02.008_bb0265","doi-asserted-by":"crossref","first-page":"O230","DOI":"10.1111\/1469-0691.12383","article-title":"Differential gene expression of activating Fc\u03b3 receptor classifies active tuberculosis regardless of human immunodeficiency virus status or ethnicity","volume":"20","author":"Sutherland","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"issue":"5","key":"10.1016\/j.yexmp.2017.02.008_bb0270","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1183\/09031936.00091010","article-title":"Hypercytokinaemia accompanies HIV-tuberculosis immune reconstitution inflammatory syndrome","volume":"37","author":"Tadokera","year":"2011","journal-title":"Eur. Respir. J."},{"issue":"11","key":"10.1016\/j.yexmp.2017.02.008_bb0275","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1212\/WNL.0b013e31822e55e7","article-title":"Immune reconstitution inflammatory syndrome in natalizumab-associated PML","volume":"77","author":"Tan","year":"2011","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.yexmp.2017.02.008_bb0280","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1097\/QAD.0b013e328361648b","article-title":"Modulation of the complement system in monocytes contributes to tuberculosis-associated immune reconstitution inflammatory syndrome","volume":"27","author":"Tran","year":"2013","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.yexmp.2017.02.008_bb0285","doi-asserted-by":"crossref","first-page":"32","DOI":"10.7326\/M14-2979","article-title":"Optimal timing of antiretroviral therapy initiation for HIV-infected adults with newly diagnosed pulmonary tuberculosis: a systematic review and meta-analysis","volume":"163","author":"Uthman","year":"2015","journal-title":"Ann. Intern. Fortschr. Med."},{"issue":"2","key":"10.1016\/j.yexmp.2017.02.008_bb0290","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1128\/CMR.15.2.294-309.2002","article-title":"Innate immunity to Mycobacterium tuberculosis","volume":"15","author":"van Crevel","year":"2002","journal-title":"Clin. Microbiol. Rev."},{"issue":"2","key":"10.1016\/j.yexmp.2017.02.008_bb0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054145","article-title":"Complications of antiretroviral therapy initiation in hospitalised patients with HIV-associated tuberculosis","volume":"8","author":"van der Plas","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.yexmp.2017.02.008_bb0300","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nmeth.1322","article-title":"Universal sample preparation method for proteome analysis","volume":"6","author":"Wisniewski","year":"2009","journal-title":"Nat. Methods"},{"issue":"6","key":"10.1016\/j.yexmp.2017.02.008_bb0305","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.autrev.2010.11.009","article-title":"The kaleidoscope of glucorticoid effects on immune system","volume":"10","author":"Zen","year":"2011","journal-title":"Autoimmun. Rev."}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480016302878?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480016302878?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,24]],"date-time":"2022-07-24T03:47:35Z","timestamp":1658634455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480016302878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0014480016302878"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2017.02.008","relation":{},"ISSN":["0014-4800"],"issn-type":[{"type":"print","value":"0014-4800"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TB-IRIS: Proteomic analysis of in vitro PBMC responses to Mycobacterium tuberculosis and response modulation by dexamethasone","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2017.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Francis Crick Institute. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}